Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference

2 years ago

WIXOM, Mich., March 09, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical…

Omada Health Announces Integrated Behavioral Health Support Across Chronic Care Programs

2 years ago

The digital health company deepens its investment in behavioral health across core programsSAN FRANCISCO, March 09, 2022 (GLOBE NEWSWIRE) --…

Fortress Biotech to Participate in Three March 2022 Investor Conferences

2 years ago

MIAMI, March 09, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently…

Alpha Pro Tech, Ltd. Announces Fourth Quarter and Year Ended December 31, 2021 Financial Results

2 years ago

Sales for 2021 of $68.6 million, Second Highest in Company History, Only Exceeded by Record Year Comparable Sales in 2020…

Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support

2 years ago

Ortho Care® Service and Support recognized for dedication to solving customer challenges with unique solutions that deliver exceptional patient careRARITAN,…

BBS Bioactive Bone Substitutes Plc has filed the CE-marking application of Artebone® bone void filler to the authorities

2 years ago

BBS-Bioactive Bone Substitutes Plc, Company Release, Inside Information, March 9, 2022 at 3:30 p.m.  BBS Bioactive Bone Substitutes Plc has…

Dentsply Sirona Announces $150 Million Accelerated Share Repurchase Program

2 years ago

CHARLOTTE, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that it has…

eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model

2 years ago

CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing company developing human-compatible (HuCo™) organs and cells, today announced…

Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th

2 years ago

LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),…

Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting

2 years ago

Company to Present Adhesions Prevention Data on Wednesday, March 16, 2022, at 8:30 a.m. ETCARLSBAD, Calif., March 09, 2022 (GLOBE…